Pharmaceutical

Repare bags $40m from Roche as solid tumour trial begins

The milestone-based payment came from Roche after Repare dosed the first patient with personalised solid-tumour treatment camonsertib.

Jan 25, 2024 - 18:00
Repare bags $40m from Roche as solid tumour trial begins
The milestone-based payment came from Roche after Repare dosed the first patient with personalised solid-tumour treatment camonsertib.
Read the original article

Tags:

Previous Article

Lava signs collaboration agreement with MSD for prostate cancer therapy

Next Article

Gilead’s Tecartus escapes harsher classwide boxed warning for CAR-T therapies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

NICE recommends Idorsia’s chronic insomnia treatment for UK patients

NICE recommends Idorsia’s chronic insomnia treatment fo...

Sep 15, 2023

A neuropsychologist clarifies science on aging and memory in wake of Biden special counsel report

A neuropsychologist clarifies science on aging and memo...

Feb 9, 2024

Microsoft and NVIDIA expand collaboration in healthcare innovation

Microsoft and NVIDIA expand collaboration in healthcare...

Mar 20, 2024